Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals
Crossref DOI link: https://doi.org/10.1007/s11151-018-9621-4
Published Online: 2018-03-06
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kremer, Michael
Snyder, Christopher M.
Text and Data Mining valid from 2018-03-06
Article History
First Online: 6 March 2018